Bylaws
The OPTN bylaws address the governance structure and roles of the OPTN. Note: prior to December 2, 2024, material that relates to OPTN management and membership was included within the OPTN Bylaws. This content is now addressed on the OPTN Management and Membership Policies page.
Also as of July 24, 2024, the Independent Network for Equitable and Safe Transplants (INVEST) was established to serve as the OPTN Board of Directors through a designation agreement issued by the Health Resources and Services Administration (HRSA). References in the OPTN Bylaws to INVEST are in the context of that relationship.
OPTN Bylaws
The OPTN Bylaws focus on the structure and operation of the Board of Directors and OPTN governance.
OPTN Bylaws Updated 12/2/2024Recent updates
The OPTN Management and Membership Policies were last updated on 7/25/2024 with changes related to Enhance Transplant Program Performance Monitoring System, Phase 3.
Update | Section | Effective date |
---|---|---|
Enhance Transplant Program Performance Monitoring System, Phase 3 |
Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs |
7/25/2024 |
Establish Code of Conduct and Whistleblower Protections |
2.7: OPTN Code of Conduct 2.9 Public Statements by Directors 2.10 Whistleblower Protection 7.8 OPTN Code of Conduct 7.9 Public Statements by Committee Members and OPTN Volunteers 9.5 Review Boards |
7/1/2024 |
Proposal to Address the Relationship of the OPTN and OPTN Contractor Board |
2.8: Relationship of the OPTN Board and the OPTN Contractor |
3/30/2024 |
Establish Membership Requirements for Uterus Transplant Programs |
Appendix J: Membership Requirements for Vascularized
|
12/5/2023 |
Apply Transplant Notification Requirements for VCA Program Inactivation (PDF) |
Appendix J: Membership and Personnel Requirements for Appendix K: Transplant Program Inactivity, Withdrawal, |
09/14/2023 |
Enhance Transplant Program Performance Monitoring System, Phase 2 (July 2023) (PDF)
|
Appendix D, D.12.A: Transplant Program Performance except adult and pediatric criteria for pre-transplant mortality rate ratio |
07/27/2023 |
OPTN Bylaws Corrections 2022
|
Appendix C.3.A: Histocompatibility Laboratory Director Qualifications Appendix M: Definitions |
12/5/2022 |
Enhance Transplant Program Performance Monitoring System, Phase 1 (July 2022) (PDF)
|
Appendix D, D.12.A.: Transplant Program Performance except adult and pediatric criteria for pre-transplant mortality rate ratio and offer acceptance rate ratio Appendix L, L.3: Medical Peer Review Appendix L, L.6: Peer Visits Appendix L, L.9: Informal Discussions Appendix L, L.15: Costs and Expenses Appendix M: Definitions |
07/14/2022 |
Correction to Primary Pediatric Liver Transplant Program Requirements (PDF) |
F.4.E.4: Combined Pediatric Gastroenterology/Transplant Hepatology Training and Experience Pathway F.7.C.2.d: Conditional Approval for a Pediatric Component |
6/27/2022 |
Administrative Changes |
1.1.E: Member Compliance 3.1: Composition |
12/6/2021 |
Clarification of Policies and Bylaws Specific to Vascularized Composite Allografts (PDF) |
Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs Appendix M: Definitions |
06/14/2021 |
List Covered Body Parts for VCA |
D: Membership Requirements for Transplant Hospitals and Transplant Programs D.3: Designated Transplant Program Requirement J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs J.3: Primary VCA Transplant Surgeon Requirements M: Definitions |
06/14/2021 |
Align VCA Program Membership Requirements with Other Programs |
D.7: Transplant Program Key Personnel J: Membership and Personnel Requirements for Vascularized Composite Allograft (VCA) Transplant Programs J.1: Program Director, Primary Transplant Physician, and Primary Transplant Surgeon J.2: Primary VCA Transplant Physician Requirements J.3 Primary VCA Transplant Surgeon Requirements |
06/14/2021 |
Membership Requirements for VCA Transplant Programs |
J: Membership and Personnel Requirements for Vascularized Composite Allograft (VCA) Transplant Programs J.1: Program Director, Primary Transplant Physician, and Primary Transplant Surgeon J.2: Primary VCA Transplant Physician Requirements J.3 Primary VCA Transplant Surgeon Requirements |
06/14/2021 |